Public disclosures

Soni Manmeet Singh

Company insiders · COO and CFO · Director · Summit Therapeutics Inc.

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-16.Following & alerts
Reported transaction lines
2
Buy lines
0
Sell lines
0

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-112

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
Soni Manmeet Singh

COO and CFO · Director · Summit Therapeutics Inc.

SMMT

Summit Therapeutics Inc.

Exercise or conversion
Filing details

SEC transaction code M

Stock Option (right to buy) · Derivative security · Direct ownership · Reported balance after transaction: 100000 · On November 16, 2026, the Reporting Person exercised an option to purchase 100,000 shares of the Issuer's common stock at an exercise price of $1.37 per share. · The option was granted on December 23, 2019. The shares underlying the option vested in four equal annual installments, with the first such installment beginning on December 23, 2020.

2026-11-162026-11-16

100,000 shares/units

SEC 4
Soni Manmeet Singh

COO and CFO · Director · Summit Therapeutics Inc.

SMMT

Summit Therapeutics Inc.

Exercise or conversion
Filing details

SEC transaction code M

Common Stock · Direct ownership · Reported balance after transaction: 3224375 · On November 16, 2026, the Reporting Person exercised an option to purchase 100,000 shares of the Issuer's common stock at an exercise price of $1.37 per share. · Holdings include shares previously acquired through exempt transactions pursuant to the Issuer's employee stock purchase plan.

2026-11-162026-11-16

100,000 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement